Literature DB >> 25140667

Langerhans Cell Hyperplasia From Molluscum Contagiosum.

Alyn D Hatter1, Xin Zhou, Kord Honda, Daniel L Popkin.   

Abstract

Langerhans cell histiocytosis (LCH) carries a prognosis, which ranges from benign to potentially fatal. There is currently little framework to decipher metrics, which predict the benign versus aggressive nature of LCH. We wanted to determine whether molluscum contagiosum virus (MCV) DNA could be isolated from a cutaneous lesion, demonstrating Langerhans cell hyperplasia resembling LCH in a patient with both. Polymerase chain reaction on biopsy-proven MCV and the hyperplastic lesion has been performed. Two specific regions within the MCV genome were detected from both biopsies. The authors report our findings and suggest that some MCV can produce histological lesions resembling LCH, similar to the literature on scabies mimicking LCH. Efforts to find a reactive "driver" in LCH may significantly inform the clinical scenario.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25140667      PMCID: PMC4334759          DOI: 10.1097/DAD.0000000000000201

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  13 in total

1.  Scabies masquerading as Letterer-Siwe's disease.

Authors:  K Aterman; V W Krause; J B Ross
Journal:  Can Med Assoc J       Date:  1976-09-04       Impact factor: 8.262

2.  Nodular 'pure' mucocutaneous histiocytosis X in an adult.

Authors:  R Caputo; R Gianotti; M Monti
Journal:  Arch Dermatol       Date:  1987-10

3.  Cutaneous histiocytosis with Langerhans cell features induced by scabies: a case report.

Authors:  N Y Talanin; S S Smith; E D Shelley; W B Moores
Journal:  Pediatr Dermatol       Date:  1994-12       Impact factor: 1.588

4.  Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.

Authors:  Carl E Allen; Liunan Li; Tricia L Peters; Hon-Chiu Eastwood Leung; Alexander Yu; Tsz-Kwong Man; Sivashankarappa Gurusiddappa; Michelle T Phillips; M John Hicks; Amos Gaikwad; Miriam Merad; Kenneth L McClain
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

5.  Human cytomegalovirus infection in foci of Langerhans cell histiocytosis.

Authors:  Y Kawakubo; H Kishimoto; Y Sato; K Yanagimoto; T Tsuruta; Y Ogawa; T Kameya
Journal:  Virchows Arch       Date:  1999-02       Impact factor: 4.064

6.  Development of Langerhans cell histiocytosis associated with chronic active Epstein-Barr virus infection.

Authors:  Naoki Sakata; Naomi Toguchi; Masatomo Kimura; Masahiro Nakayama; Keisei Kawa; Tsukasa Takemura
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167

7.  Langerhans cell histiocytosis: a primary viral infection of bone? Human herpes virus 6 latent protein detected in lymphocytes from tissue of children.

Authors:  Michael P Glotzbecker; David F Carpentieri; John P Dormans
Journal:  J Pediatr Orthop       Date:  2004 Jan-Feb       Impact factor: 2.324

8.  Sarcoptes scabiei infestation misdiagnosed and treated as Langerhans cell histiocytosis.

Authors:  Joanna M Burch; Alfons Krol; William L Weston
Journal:  Pediatr Dermatol       Date:  2004 Jan-Feb       Impact factor: 1.588

9.  Detection of Molluscum contagiosum virus (MCV) subtype I as a single dominant virus subtype in Molluscum lesions from a Turkish population.

Authors:  Yunus Saral; Ahmet Kalkan; Aykut Ozdarendeli; Yasemin Bulut; Mehmet Z Doymaz
Journal:  Arch Med Res       Date:  2006-04       Impact factor: 2.235

10.  Herpes-virus infection in patients with Langerhans cell histiocytosis: a case-controlled sero-epidemiological study, and in situ analysis.

Authors:  Eric Jeziorski; Brigitte Senechal; Thierry Jo Molina; Francis Devez; Marianne Leruez-Ville; Patrice Morand; Christophe Glorion; Ludovic Mansuy; Joel Gaudelus; Marianne Debre; Francis Jaubert; Jean-Marie Seigneurin; Caroline Thomas; Irene Joab; Jean Donadieu; Frederic Geissmann
Journal:  PLoS One       Date:  2008-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.